Neurology Devices Market Size & Growth Forecast 2027–2036, By Segments (Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Neurology Devices Market size stood at USD 15.1 billion in 2026 and is predicted to grow at a 7.98% CAGR from 2027 to 2036, attaining USD 32.54 billion by 2036. The industry revenue for 2027 is calculated at USD 16.11 billion.
Get more details on this report
Request Free Sample ReportNeurology Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 42.08% market share in 2026, supported by advanced clinical infrastructure, high procedure volumes, and widespread adoption of neurological diagnostic and therapeutic devices across specialized care settings.
- Asia Pacific is projected to grow at a 10.06% CAGR, fueled by expanding hospital capacity, improving healthcare access, and rising investment in advanced neurological diagnosis and interventional treatment services.
Segment Momentum
- Neurostimulation held a 57.32% market share in 2026 due to its broad use in long-term management of chronic neurological conditions, supported by established clinical familiarity and recurring demand for implantable, programmable device-based therapies.
- Interventional Neurology is growing fastest as healthcare providers increasingly adopt procedure-driven approaches for acute and complex neurological conditions that require faster diagnosis-to-treatment pathways and targeted hospital-based interventions.
Market Expansion Drivers
- Rising prevalence of Alzheimer’s and Parkinson’s disease driving advanced neurodiagnostic device demand.
- Growth in neurostimulation technologies improving treatment outcomes for neurological and psychiatric disorders.
- Expansion of home-based neuro-monitoring and wearable brain health devices improving patient accessibility.
Leading Market Participants
- Major players in the neurology devices market include Medtronic plc (Ireland), Abbott Laboratories (United States), Boston Scientific Corporation (United States), Stryker Corporation (United States), Johnson & Johnson (United States), Penumbra, Inc. (United States), LivaNova PLC (United Kingdom), NeuroPace, Inc. (United States), Zimmer Biomet Holdings, Inc. (United States), MicroVention, Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 15.1 billion
- 2027 Estimated Market Size: USD 16.11 billion.
- Projected Market Size: USD 32.54 billion by 2036
- Growth Forecast: 7.98% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Neurostimulation (Product)
- Emerging Opportunity Segment: Interventional Neurology (Product)
Market Growth Drivers and Industry Trends
Rising prevalence of Alzheimer’s and Parkinson’s disease driving advanced neurodiagnostic device demand
The rising burden of alzheimer’s and parkinson’s disease will drive neurology devices market growth by increasing the need for accurate and timely neurological assessment, diagnosis, and disease monitoring. As these progressive disorders require ongoing clinical evaluation, healthcare providers increasingly rely on advanced neurodiagnostic devices to assess brain and nervous system function and support treatment decisions. Greater emphasis on early identification and continuous monitoring can also encourage healthcare facilities to adopt sophisticated diagnostic technologies capable of providing detailed neurological information.
Growth in neurostimulation technologies improving treatment outcomes for neurological and psychiatric disorders
Advancements in neurostimulation are strengthening the neurology devices market as these technologies provide targeted approaches for managing neurological and psychiatric disorders. Neurostimulation devices can modulate neural activity through controlled electrical stimulation, supporting treatment strategies for conditions where conventional therapeutic approaches may provide limited results. Continued development of more precise stimulation techniques, improved device functionality, and broader clinical applications can increase adoption among healthcare providers seeking treatment options that improve symptom management and patient outcomes.
Expansion of home-based neuro-monitoring and wearable brain health devices improving patient accessibility
Expansion of remote care is creating new opportunities for the neurology devices market, particularly through home-based neuro-monitoring and wearable brain health technologies. These devices enable patients to collect and monitor neurological information outside conventional clinical settings, reducing dependence on frequent hospital visits and supporting continuous observation of changes in neurological conditions. Wearable and remotely connected solutions can also facilitate greater patient participation in disease management while allowing healthcare professionals to obtain relevant monitoring information during routine care.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of Alzheimer’s and Parkinson’s disease driving advanced neurodiagnostic device demand | 2.30% | High | North America, Europe | High | Near Term |
| Growth in neurostimulation technologies improving treatment outcomes for neurological and psychiatric disorders | 2.10% | High | North America, Asia Pacific | High | Mid Term |
| Expansion of home-based neuro-monitoring and wearable brain health devices improving patient accessibility | 1.80% | Moderate | North America, Europe | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held a 42.08% share of the neurology devices market in 2026, supported by advanced neurological care infrastructure, high adoption of sophisticated diagnostic and therapeutic technologies, and substantial investment in medical research. The region benefits from growing demand for devices used in the management of neurological disorders, including technologies for diagnosis, monitoring, neurosurgery, and minimally invasive treatment. An aging population, increasing focus on early detection, and continued innovation in neurostimulation and imaging technologies are further reinforcing regional demand.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, driven by expanding healthcare infrastructure, rising awareness of neurological disorders, and improving access to specialized medical care. Growing healthcare expenditure and the modernization of hospitals are enabling wider adoption of advanced neurological diagnostic and treatment technologies. The increasing prevalence of age-related neurological conditions, combined with efforts to strengthen specialist care and introduce less invasive treatment approaches, is creating significant opportunities for neurology device adoption across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Clinical SolutionsGermany prioritizes neurology devices that deliver reliable diagnostics, surgical precision, and efficient patient management within specialized neurological care. German healthcare providers increasingly adopt advanced imaging and neurostimulation technologies to support complex treatment pathways.
France 🇫🇷
Specialized Treatment NetworksFrance strengthens neurology device adoption through coordinated specialist care and hospital investment in advanced neurological diagnostics. Healthcare providers across France increasingly focus on technologies that improve treatment planning and long-term patient management.
Italy 🇮🇹
Hospital Equipment RenewalItaly continues modernizing neurology device infrastructure as hospitals replace legacy equipment with advanced diagnostic and therapeutic systems. Italian healthcare providers prioritize technologies that improve procedural efficiency while supporting comprehensive neurological care across regional health networks.
Japan 🇯🇵
Aging Care TechnologiesJapan focuses on neurology devices that address rising demand for diagnosis and management of age-related neurological conditions. Healthcare providers in Japan continue integrating compact, high-precision technologies that improve efficiency across hospitals and specialist clinics.
South Korea 🇰🇷
Digital Neurology IntegrationSouth Korea combines neurology devices with digital healthcare capabilities to enhance diagnosis, monitoring, and clinical decision-making. Hospitals in South Korea increasingly invest in advanced neurological technologies that support precision treatment and connected patient care.
United States 🇺🇸
Innovation-Centered CareThe U.S. neurology devices market emphasizes advanced diagnostic and therapeutic technologies that support earlier intervention and improved clinical workflows. Healthcare providers in the U.S. continue adopting minimally invasive and digitally connected neurological solutions across specialized care settings.
Segment Leadership and Growth Trends
Neurology Devices Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Neurostimulation (Largest Segment) vs Interventional Neurology (Fastest-Growing Segment)
Neurostimulation represented the largest segment of the neurology devices market, accounting for 57.32% share in 2026. Its strong position is driven by the expanding use of electrical stimulation technologies in managing neurological disorders and chronic conditions where conventional treatment approaches may provide limited relief. Neurostimulation can offer targeted therapeutic intervention while supporting personalized treatment strategies, making it increasingly relevant across pain management and neurological care. Continued clinical adoption, advances in device design, and growing demand for less invasive treatment options are reinforcing the segment's established market position.
Interventional neurology is experiencing faster growth as healthcare providers increasingly adopt minimally invasive approaches for the diagnosis and treatment of complex neurological and cerebrovascular conditions. These technologies enable targeted procedures through catheter-based and other specialized techniques, reducing the need for more invasive surgical interventions in appropriate cases. Rising emphasis on rapid treatment, improved procedural precision, and advancements in image-guided neurological interventions are supporting greater adoption of interventional approaches.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Neurostimulation, Interventional Neurology, CSF Management Devices, Neurosurgery Devices | Neurostimulation | Interventional Neurology |
Competitive Landscape and Market Positioning
Prominent players in the neurology devices market:
1. Medtronic plc (Ireland)
2. Abbott Laboratories (United States)
3. Boston Scientific Corporation (United States)
4. Stryker Corporation (United States)
5. Johnson & Johnson (United States)
6. Penumbra Inc. (United States)
7. LivaNova PLC (United Kingdom)
8. NeuroPace Inc. (United States)
9. Zimmer Biomet Holdings Inc. (United States)
10. MicroVention Inc. (United States)
Rising neurological disorder prevalence is increasing demand for advanced diagnostic and therapeutic devices. The neurology devices market is evolving through improved imaging precision and minimally invasive treatment solutions. Continuous innovation is strengthening clinical accuracy and patient outcome optimization.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Medtronic plc (Ireland) | |||||||
| Abbott Laboratories (United States) | |||||||
| Boston Scientific Corporation (United States) | |||||||
| Stryker Corporation (United States) | |||||||
| Johnson & Johnson (United States) | |||||||
| Penumbra Inc. (United States) | |||||||
| LivaNova PLC (United Kingdom) | |||||||
| NeuroPace Inc. (United States) | |||||||
| Zimmer Biomet Holdings Inc. (United States) | |||||||
| MicroVention Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Medtronic | Feb-25 | Medtronic received FDA approval for its BrainSense Adaptive Deep Brain Stimulation system for Parkinson’s disease, enabling real-time, signal-responsive neuromodulation. The system enhances personalization of therapy and strengthens Medtronic’s position in advanced neuromodulation technologies. |
| Stryker | Sep-24 | Stryker acquired NICO Corporation to strengthen its minimally invasive neurotechnology portfolio for tumor and intracerebral hemorrhage procedures. The acquisition enhances Stryker’s capabilities in neurointerventional surgery and expands its presence in advanced brain and stroke care solutions. |
| AbbVie | Aug-24 | AbbVie acquired Cerevel Therapeutics for approximately USD 8.7 billion, gaining access to a pipeline of clinical and preclinical neurology and psychiatry candidates. The acquisition significantly expands AbbVie’s neuroscience portfolio and strengthens its long-term neurology drug development capabilities. |
| GE HealthCare | Apr-24 | GE HealthCare acquired MIM Software to enhance its medical imaging analytics and AI capabilities across neurology and oncology applications. The integration strengthens digital workflow solutions and supports expanded diagnostic and treatment planning capabilities in neuroimaging. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Neurology Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Disease Indication | Epilepsy, Parkinson's Disease & Movement Disorders, Stroke & Cerebrovascular Disorders, Alzheimer's Disease & Dementia, Chronic Pain, Other Neurological Disorders |
| Procedure Type | Diagnostic Procedures, Therapeutic Procedures, Surgical Procedures, Monitoring & Evaluation Procedures |
| Healthcare Setting | Hospitals, Specialty Neurology Centers, Ambulatory Surgical Centers, Outpatient Clinics, Research & Academic Institutions |
Neurology Devices Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Clinical Adoption Pathway Assessment |
|
| Hospital Capital Equipment Procurement Outlook |
|
| Neuroscience Innovation Pipeline Landscape |
|
Need a different cut of the data?
Request Custom ResearchHow much is the neurology devices market worth?
What is the expected industry size of neurology devices by 2036?
How is the need for earlier and more precise neurological diagnosis reshaping device procurement strategies?
Why is neurostimulation becoming a more central component of treatment pathways in neurological care?
Why does the Neurostimulation segment lead the neurology devices market?
Why is Interventional Neurology the fastest-growing product segment?
Why does North America lead the neurology devices market?
What is driving growth in the neurology devices market across Asia Pacific?
What are the key competitors in the neurology devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization